- Home
- ARVN vs BWB Comparison
ARVN vs BWB Comparison
Compare ARVN & BWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- BWB
- Stock Information
- Founded
- ARVN 2015
- BWB 2005
- Country
- ARVN United States
- BWB United States
- Employees
- ARVN N/A
- BWB N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- BWB Major Banks
- Sector
- ARVN Health Care
- BWB Finance
- Exchange
- ARVN Nasdaq
- BWB Nasdaq
- Market Cap
- ARVN 456.2M
- BWB 412.1M
- IPO Year
- ARVN 2018
- BWB 2018
- Fundamental
- Price
- ARVN $7.80
- BWB $15.91
- Analyst Decision
- ARVN Buy
- BWB Strong Buy
- Analyst Count
- ARVN 21
- BWB 2
- Target Price
- ARVN $20.53
- BWB $18.00
- AVG Volume (30 Days)
- ARVN 2.2M
- BWB 61.2K
- Earning Date
- ARVN 07-29-2025
- BWB 07-23-2025
- Dividend Yield
- ARVN N/A
- BWB N/A
- EPS Growth
- ARVN N/A
- BWB N/A
- EPS
- ARVN N/A
- BWB 1.10
- Revenue
- ARVN $426,900,000.00
- BWB $111,392,000.00
- Revenue This Year
- ARVN $4.26
- BWB $32.02
- Revenue Next Year
- ARVN N/A
- BWB $11.47
- P/E Ratio
- ARVN N/A
- BWB $14.44
- Revenue Growth
- ARVN 498.74
- BWB 3.73
- 52 Week Low
- ARVN $5.90
- BWB $10.88
- 52 Week High
- ARVN $34.11
- BWB $16.34
- Technical
- Relative Strength Index (RSI)
- ARVN 58.03
- BWB 66.51
- Support Level
- ARVN $7.09
- BWB $14.80
- Resistance Level
- ARVN $7.85
- BWB $15.35
- Average True Range (ATR)
- ARVN 0.40
- BWB 0.29
- MACD
- ARVN 0.06
- BWB 0.09
- Stochastic Oscillator
- ARVN 71.43
- BWB 93.83
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.